Page last updated: 2024-08-26

n-succinimidyl 3-(2-pyridyldithio)propionate and Cancer of Prostate

n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carter, T; Doughty, L; Guthrie, R; Hattarki, M; Hewish, D; Kortt, AA; Molloy, PL; Ow, K; Russell, PJ; Shapira, D; Sterling-Levis, K; Werkmeister, JA1

Other Studies

1 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Cancer of Prostate

ArticleYear
Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies.
    Cancer immunology, immunotherapy : CII, 2004, Volume: 53, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Division; Cross-Linking Reagents; Cytotoxicity, Immunologic; Flow Cytometry; Humans; Immunoconjugates; In Vitro Techniques; Male; Melitten; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Peptide Fragments; Prostatic Neoplasms; Succinimides; Survival Rate; Tumor Cells, Cultured

2004